A novel multiple reactor system for the long-term production of L-asparaginase by Penicillium sp. LAMAI 505

In this paper a novel system of multiple reactors with immobilized cells (MRICs) to produce l-asparaginase by Penicillium sp. LAMAI 505 is presented. The effects of the number of associated reactors, nutrient composition, residence time for nutrient cycling, and extraction cycles were investigated using an artificial neural network (ANN). The ANN model was satisfactory (R² > 0.85 with an error lower than 2.4%) and the MRICs performed well when compared to the literature. The cyclic operation of the MRICs can regenerate cells within the inert support, allowing for the long-term production of l-asparaginase. l-asparaginase activity of 13.7 U/gds was achieved under optimised conditions that included a residence time of 33.5 min, pH of 5.1, and concentrations of l-asparagine and glucose of 1.2 and 3.0 g/L, respectively. Furthermore, we demonstrate that MRICs are effective with other fungi and can be used for other products.     

Localization and production of novel l-asparaginase from Pectobacterium carotovorum MTCC 1428

Bacterial l-asparaginase has been widely used as therapeutic agent in the treatment of various lymphoblastic leukemia diseases. Studies on localization and production of novel glutaminase-free l-asparaginase were performed using Pectobacterium carotovorum MTCC 1428. The localization of l-asparaginase was carried out using cell fractionation techniques. The activity of l-asparaginase was found to be 85 and 77% in the cytoplasm of P. carotovorum MTCC 1428 grown on medium containing l-asparagine and combination of l-asparagine and glucose respectively. Among the tested carbon sources, l-asparagine or the combination of l-asparagine and glucose was found to be the most suitable carbon sources to maximize the production of l-asparaginase. The maximum production of l-asparaginase was observed to be 14.56 U/ml (26.92 U/mg of protein) at 4 and 2 g/l of l-asparagine and glucose respectively. Yeast extract, l-asparagine and peptone have shown significant effect on the production of l-asparaginase. P. carotovorum MTCC 1428 has assimilated l-asparagine as an essential carbon source for maximizing the production of l-asparaginase.     

Regulation of Escherichia colil-asparaginase II and l-aspartase by the fnr gene-product

l-asparaginase II and l-aspartase, which are known to be regulated by oxygen in Escherichia coli, are shown, by an examination of known fnr mutants, to be under the control of the fnr gene product. Mutants obtained from a procedure devised to select for asparaginase II-deficiency are fnr⁻.     

Control of process-induced asparaginyl deamidation during manufacture of Erwinia chrysanthemi l-asparaginase

During the manufacture of the chemotherapeutic enzyme Erwinia chrysanthemi l-asparaginase, a small proportion (approximately 5–15%) of acidic variants, including deamidated species, are observed. Although the deamidated forms appear to have similar specific activity and quaternary structure to the unmodified enzyme, monitoring and control of these forms is important from a regulatory perspective. The extent of Asn to Asp deamidation directly correlates with the time taken to thaw the Erwinia cells. Erwinia l-asparaginase is a tetrameric enzyme containing one site, Asn₂₈₁, theoretically very labile to deamidation due to the sequence Asn-Gly. Structurally, this part of the protein sequence is completely buried inside the tetramer, but solvent-exposed upon tetramer dissociation. During the cell thawing and alkaline lysis sequence of the process, lengthening the cell thaw times by up to 24 h allowed tetramer to reassociate, protected Asn₂₈₁ from deamidation and reduced the acidic species content of the l-asparaginase from approximately 17% to 9% as measured by weak cation-exchange (WCX) HPLC. The correlation of cell thaw time with acidic species content was also confirmed using capillary zone electrophoresis (CZE) and peptide mapping. These studies demonstrate that cell thaw time is an important, if unexpected, control variable for l-asparaginase deamidation.     

A radiometric method for the measurement of l-asparaginase at concentrations below 1 × 10−5 I.U./ml: Technique and application

A radiometric method for the measurement of low levels of l-asparaginase activity (EC 3.5.1.1) has been devised. This technique uses a protracted incubation at 37°C to magnify amidohydrolytic activity. During this time, in most of the cases examined, l-[U-¹⁴C]asparagine is hydrolyzed to l-[U-¹⁴C]aspartic acid in a linear way; the l-[U-¹⁴C]aspartic acid so generated is transaminated with α-ketoglutaric acid by l-glutamic acid oxaloacetate transaminase (EC 2.6.1.1) and the [U-¹⁴C]oxaloacetic acid so formed is β-decarboxylated by Zn²⁺ at pH 5.0. Using this procedure, low levels of l-asparaginase have been detected in the serum of the chicken, horse, and ox. Use also has been made of maleimide, which inhibits mammalian l-asparaginase without affecting the enzymes from bacterial sources, to discount the possibility that bacterial contamination of mammalian samples was responsible for the activity seen. When a survey was conducted of the distribution of l-asparaginase in the organs of Mus musculus, testis was found to contain surprisingly high levels of the analogous hydrolase from liver. The applicability of this technique to the measurement of feeble activities of l-asparaginase leeched from Dacron tubing to which l-asparaginase has been covalently bound, also has been demonstrated.     

Effect of Glucose and Low Oxygen Tension on l-Asparaginase Production by a Strain of Escherichia coli B

Cultural and nutritional requirements for maximum l-asparaginase synthesis were determined. Conventional aerobic and anaerobic fermentations were not satisfactory. The former yielded larger quantities of cells containing minimal amounts of l-asparaginase, whereas the latter supplied only minute amounts of bacteria that contained an abundance of enzyme. However, the combination of these classical methods, i.e., allowing growth to proceed aerobically until the mid to late exponential phase and then forcing the facultative microbial cells toward anaerobic metabolism by static incubation, produced 2.6 international units of enzyme per ml of fermentation broth when glucose was present. Enzyme synthesis was not induced by terminating aeration-agitation in the absence of glucose, nor was it induced in the presence of glucose when aeration was continued. Use of 0.2 m phosphate buffer resulted in a constant pH near the optimum value of 7.5 during l-asparaginase formation. Addition of 0.05% l-asparagine prior to induction was also beneficial, but other amino acids or their catabolites failed to increase biosynthesis of l-asparaginase.     

粪便微生物宏基因组来源L-天冬酰胺酶的性质表征及应用研究

l-天冬酰胺酶是氨基酸代谢的关键酶,广泛应用于食品和医药领域,肠道菌群及其产生的l-天冬酰胺酶与宿主健康和疾病关系密切。【目的】获取肠道微生物来源的新型l-天冬酰胺酶,并对其进行性质表征和应用研究。【方法】以西黑冠长臂猿粪便微生物宏基因组为模板,克隆l-天冬酰胺酶基因,并在大肠杆菌中表达;对表达出的酶进行酶学性质研究,并用于处理薯条和癌细胞。【结果】克隆获得l-天冬酰胺酶基因NCasn5,全长996 bp,重组酶NCasn5分子量大小为37.296 kDa,最适pH为8.0,最适温度为60 ℃,K_m和V_max值分别为(3.33±0.21) mmol/L和(836.30±13.91)µmol/(min·mg),37 ℃体外血清半衰期约69 h。NCasn5能降低薯条中69.35%的丙烯酰胺含量,抑制人肝癌细胞QGY-7703和人恶性黑色素瘤细胞A-375细胞的生长。【结论】本研究获得的新型l-天冬酰胺酶,具有良好的热稳定性和较长的血清半衰期,不仅无谷氨酰胺酶活性,还能减少油炸薯条中丙烯酰胺的含量,也能诱导癌细胞QGY-7703和A-375凋亡,在食品加工及医药领域具有潜在的应用价值。     

New procedures for purification of L-asparaginase with high yield from Escherichia coli

l-Asparaginase is now known to be a potent antineoplastic agent in animals and has given complete remission in some human leukemias. Extensive clinical trials of this enzyme, however, were not possible in the past because of inadequate production of this substance. We have developed practical procedures for producing l-asparaginase in yields of sufficient quantity and purity for more extensive clinical evaluation. The nutritional requirements for optimal production of biologically active l-asparaginase by a strain of Escherichia coli have been ascertained. The highest yields of enzyme were obtained when cells were grown aerobically in a corn steep medium. Good enzyme production was associated with media containing l-glutamic acid, l-methionine, and lactic acid. The addition of glucose to the medium, however, resulted in depressed production of l-asparaginase. Sodium ion appeared to suppress l-asparaginase production. With the procedure described for isolation of biologically active l-asparaginase from E. coli, stable l-asparaginase preparations with a specific activity of 620 IU per mg of protein (1,240-fold purification with 40% total recovery) were obtained.     

l-Asparaginase from Proteus vulgaris

To produce an immunologically and enzymologically new type of l-asparaginase, 108 strains of bacteria were screened for enzyme production. As a result, 13 bacteria belonging to the genera Alcaligenes, Bacterium, and Proteus were found to produce l-asparaginases in high levels. Among these l-asparaginases, partially purified l-asparaginases from B. cadaveris and P. vulgaris showed antitumor activity. A partially purified l-asparaginase preparation of P. vulgaris did not react with the antibody of Escherichia colil-asparaginase on the Ouchterlony agar plate. Culture conditions for the production of l-asparaginase by P. vulgaris were investigated in detail. The enzyme was produced in high yields when cells were grown aerobically in a medium containing sodium fumarate and corn steep liquor. The addition of glucose or ammonium ion to the medium, however, resulted in depressed production of l-asparaginase. Under the optimum conditions, 3,700 international units of l-asparaginase was obtained from 1 liter of culture medium.     

Amino acid residues adjacent to the catalytic cavity of tetramer l-asparaginase II contribute significantly to its catalytic efficiency and thermostability

l-Asparaginase (l-asparagine amidohydrolase, EC 3.5.1.1) catalyzes the hydrolysis of l-asparagine to l-aspartic acid and ammonia. It can be used to reduce the formation of acrylamide, which is carcinogenic to humans in foods, via removal of the precursor, asparagine, from the primary ingredients. However, low activity and poor thermostability of l-asparaginase restrict its application in food industry. In this study, we successfully improved thermostability and catalytic efficiency of l-asparaginase II (BsAII) from Bacillus subtilis B11-06 by site-directed mutagenesis. According to sequences alignment and homologous modeling, residues G107, T109 and S166 which were adjacent to the catalytic cavity were selected and substituted by Asp, Gln/Ser and Ala, respectively, to construct mutants G107D, T109Q, T109S and S166A. The BsAII mutant of G107D (G107D_ansz) displayed superior performance in thermal tolerance and higher activity than the wild-type enzyme (towards l-asparagine). Comparative analysis of hydrogen bond interactions, surface electrostatic potential and structure of substrate binding pocket between G107D_anszand BsAII indicated that the substitution of G107, which was adjacent to catalytic cavity with Asp, resulted in small conformational changes and surface electrostatic potential redistribution and contributed to the improved protein stability and catalytic efficiency.     

Immunological aspects in the L-asparaginase treatment of children with lymphoproliferative diseases]

A group of 20 children, including 14 with acute lymphoblastic leukemia and 6 with lymphosarcoma, was studied. 24 cures of l-asparaginase therapy were carried out. The increase of serum immunoglobulin (IgG, IgA, IgM) levels was found in children treated with smaller (from 300 to 500 I.U./kg b. w.) doses of asparaginase. In the group treated with higher doses (from 501 to 760 I.U./kg b. w.) the maximal increase of immunoglobulins was observed in the second half of the cure with l-asparaginase, followed by a decrease of the immunoglobulins levels at the end of treatment. The presence of anti-asparaginase antibodies in two children with anaphylactic shocks after l-asparaginase has been shown. In these two children and 6 others the lymphocyte count significantly dropped down on the day of shock before l-asparaginase injection.     

Helicobacter pyloril-asparaginase: a promising chemotherapeutic agent

Bacterial l-asparaginases are amidohydrolases that catalyse the conversion of l-asparagine to l-aspartate and ammonia and are used as anti-cancer drugs. The current members of this class of drugs have several toxic side effects mainly due to their associated glutaminase activity. In the present study, we report the molecular cloning, biochemical characterisation and in vitro cytotoxicity of a novel l-asparaginase from the pathogenic strain Helicobacter pylori CCUG 17874. The recombinant enzyme showed a strong preference for l-asparagine over l-glutamine and, in contrast to most l-asparaginases, it exhibited a sigmoidal behaviour towards l-glutamine. The enzyme preserved full activity after 2 h incubation at 45 °C. In vitro cytotoxicity assays revealed that different cell lines displayed a variable sensitivity towards the enzyme, AGS and MKN28 gastric epithelial cells being the most affected. These findings may be relevant both for the interpretation of the mechanisms underlying H. pylori associated diseases and for biomedical applications.     

Guinea pig serum l-asparaginase: Purification, and immunological relationship to liver l-asparaginase and serum l-asparaginases in other mammals

l-asparaginase, an enzyme used in the treatment of acute lymphocytic leukemia, is found in the serum of only a few mammalian groups, including the guinea pig and its close relatives in the superfamily Cavioidea. This report describes the purification and characterization of l-asparaginase from guinea pig serum. Antiserum against the purified enzyme cross-reacted with sera from other Cavioidean species but not with mouse serum. Relatively weak cross-reaction with unpurified l-asparaginase in guinea pig liver indicates a significant degree of evolutionary divergence.     

A simple and rapid method for the estimation of L-asparaginase in chromatographic and electrophoretic effluents: comparison with other methods

Four methods for the measurement of l-asparaginase have been compared with a new modification of an enzymatic, spectrophotometric technique utilizing l-glutamate oxaloacetate transaminase and malate dehydrogenase. This last technique uses disposable polycarbonate tubes both as reaction vessels and as cuvettes. Only a single addition of reagents and a single reading of absorbance is required. The simplicity of this technique is especially helpful when the prompt analysis of many samples of l-asparaginase is desired.     

An Amplex Red-based fluorometric and spectrophotometric assay for l-asparaginase using its natural substrate

We report on the development of a sensitive real-time assay for monitoring the activity of l-asparaginase that hydrolyzes l-asparagine to l-aspartate and ammonia. In this method, l-aspartate is oxidized by l-aspartate oxidase to iminoaspartate and hydrogen peroxide (H₂O₂), and in the detection step horseradish peroxidase uses H₂O₂ to convert the colorless, nonfluorescent reagent Amplex Red to the red-colored and highly fluorescent product resorufin. The assay was validated in both the absorbance and the fluorescence modes. We show that, due to its high sensitivity and substrate selectivity, this assay can be used to measure enzymatic activity in human serum containing l-asparaginase.     

Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry

Glutamine is an abundant amino acid that plays pivotal roles in cell growth, cell metabolism, and neurotransmission. Dysregulation of glutamine-using pathways has been associated with pathological conditions such as cancer and neurodegenerative diseases. 6-Diazo-5-oxo-l-norleucine (DON) is a reactive glutamine analog that inhibits enzymes affecting glutamine metabolism such as glutaminase, 2-N-amidotransferase, l-asparaginase, and several enzymes involved in pyrimidine and purine de novo synthesis. As a result, DON is actively used in preclinical models of cancer and neurodegenerative disease. Moreover, there have been several clinical trials using DON to treat a variety of cancers. Considerations of dose and exposure are especially important with DON treatment due to its narrow therapeutic window and significant side effects. Consequently, a robust quantification bioassay is of interest. DON is a polar unstable molecule that has made quantification challenging. Here we report on the characterization of a bioanalytical method to quantify DON in tissue samples involving DON derivatization with 3 N HCl in butanol. The derivatized product is lipophilic and stable. Detection of this analyte by mass spectrometry is fast and specific and can be used to quantify DON in plasma and brain tissue with a limit of detection at the low nanomolar level.     

L-asparaginase production by isolated Staphylococcus sp. - 6A: design of experiment considering interaction effect for process parameter optimization

AIMS: Evaluation of fermentation process parameter interactions for the production of l-asparaginase by isolated Staphylococcus sp. - 6A. METHODS AND RESULTS: Fractional factorial design of experimentation (L18 orthogonal array of Taguchi methodology) was adopted to optimize nutritional (carbon and nitrogen sources), physiological (incubation temperature, medium pH, aeration and agitation) and microbial (inoculum level) fermentation factors. The experimental results and software predicted enzyme production values were comparable. CONCLUSION: Incubation temperature, inoculum level and medium pH, among all fermentation factors, were major influential parameters at their individual level, and contributed to more than 60% of total l-asparaginase production. Interaction data of selected fermentation parameters could be classified as least and most significant at individual and interactive levels. Aeration and agitation were most significant at interactive level, but least significant at individual level, and showed maximum severity index and vice versa at enzyme production. SIGNIFICANCE AND IMPACT OF THE STUDY: All selected factors showed impact on l-asparaginase enzyme production by this isolated microbial strain either at the individual or interactive level. Incubation temperature, inoculum concentration, pH of the medium and nutritional source (glucose and ammonium chloride) had impact at individual level, while aeration, agitation and incubation time showed influence at interactive level. Significant improvement (ninefold increase) in enzyme production by this microbial isolate was noted under optimized environment.     

Small-angle X-ray scattering studies of Escherichia colil-asparaginase

Small angle X-ray scattering studies on Escherichia colil-asparaginase solutions show that the enzyme has a radius of gyration of 34.0 Å ± 0.5 Å at pH 7. The radius of gyration of the dissociated monomer is 16.0 Å ± 1.0 Å; it has the general shape of a prolate ellipsoid with an axial ratio of 1.4. A tetramer of four such ellipsoids arranged with 222 symmetry gives good agreement between measured and calculated radii of gyration if the distance between subunit centers is 43 Å. The tetramer dissociates on dilution below 1% and at pH values below 3.0. Acid-induced denaturation at pH 2.0 is irreversible in contrast to the reversible guanidine-HCl-induced denaturation.     

Enhanced catalysis of l-asparaginase from Bacillus licheniformis by a rational redesign

l-Asparaginase (3.5.1.1) being antineoplastic in nature are used in the treatment of acute lymphoblastic leukemia (ALL). However glutaminase activity is the cause of various side effects when used as a drug against acute lymphoblastic leukemia (ALL). Therefore, there is a need of a novel l-asparaginase (L-ASNase) with low or no glutaminase activity. Such a property has been observed with L-ASNase from B. licheniformis (BliA). The enzyme being glutaminase free in nature paved the way for its improvement to achieve properties similar to or near to the commercially available L-ASNases. Rational enzyme engineering approach resulted in four mutants: G238N, E232A, D103V and Q112H. Among these the mutant enzyme, D103V, had a specific activity of 597.7 IU/mg, which is higher than native (rBliA) (407.65 IU/mg). Moreover, when the optimum temperature and in vitro half life were studied and compared with native BliA, D103V mutant BliA was better, showing tolerance to higher temperatures and a 3 fold higher half life. Kinetic studies revealed that the mutant D103V L-ASNase has increased substrate affinity, with K_m value of 0.42 mM and V_max of 2778.9 μmol min⁻¹.     

Crystallographic study on the orthorhombic crystal of l-asparaginase from Escherichia coli HAP

The orthorhombic crystals of l-asparaginase from Escherichia coli A-1-3 KY3598 were characterized by the X-ray diffraction method as belonging to the space group P2₁22₁ with unit cell dimensions $\text{a = 116.7}\text{A}\text{?}\text{, b = 62.9}\text{A}\text{?}\text{and}\text{c = 86.6}\text{A}\text{?}$. The crystals contain one half of the tetrameric enzyme molecule per asymmetric unit, the smallest so far reported for this enzyme. Preliminary analysis of the Patterson map indicated that the molecule had at least pseudo 222 symmetry and established the position of the centers of the molecules in the unit cell.